Activating signals dominate inhibitory signals in CD137L/IL-15 activated natural killer cells.
about
Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cellsModulation of human mesenchymal stem cell immunogenicity through forced expression of human cytomegalovirus us proteins.Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell-depleted stem cell transplantation.NK cells: immune cross-talk and therapeutic implications.NK cell-based immunotherapies in Pediatric Oncology.Interleukin-15 Dendritic Cells Harness NK Cell Cytotoxic Effector Function in a Contact- and IL-15-Dependent Manner.Cellular and Antibody Based Approaches for Pediatric Cancer Immunotherapy.Large-scale isolation and cytotoxicity of extracellular vesicles derived from activated human natural killer cells.Growth and activation of natural killer cells ex vivo from children with neuroblastoma for adoptive cell therapy.Evaluation of Functional NK Cell Responses in Vaccinated and SIV-Infected Rhesus MacaquesImmune-based therapies for childhood cancer.TRAIL-mediated killing of acute lymphoblastic leukemia by plasmacytoid dendritic cell-activated natural killer cells.Umbilical cord blood graft engineering: challenges and opportunities.Redirected Primary Human Chimeric Antigen Receptor Natural Killer Cells As an "Off-the-Shelf Immunotherapy" for Improvement in Cancer Treatment.Ex Vivo Expansion of Human NK Cells Using K562 Engineered to Express Membrane Bound IL21.Shaping of Natural Killer Cell Antitumor Activity by Ex Vivo Cultivation.Highlights of the third International Conference on Immunotherapy in Pediatric Oncology.Developmental and Functional Control of Natural Killer Cells by Cytokines.Ex Vivo Expanded Human NK Cells Survive and Proliferate in Humanized Mice with Autologous Human Immune CellsCD56bright NK cells exhibit potent antitumor responses following IL-15 priming.
P2860
Q27309991-9B7A2FBD-43B2-4566-A030-FABA1A8D5BC3Q34292404-5C618511-32C4-421F-8B3A-525DC44B6A86Q35029441-16549903-0AFA-4CB1-924D-7152B2AC2C25Q35591444-3589AE3E-801A-4BD9-93A8-4F203F25136CQ35600975-6F27E6DA-62B7-4C11-946C-2981927607C9Q35624376-20D1425E-8CBE-4E89-B1E0-9BAFE34DBA69Q36261159-3C60774D-DCA1-47F2-A9E3-8FE1EFB3D4FBQ36317164-37DFA036-453B-4F68-B343-3E5ECCA11EDAQ36856792-83105A0C-F456-4949-A8F7-361C592FE47DQ37218449-FF2855A8-6B88-4349-962E-E8346413931AQ38263108-EFCC270F-9221-4482-AE7F-F3AB26AACD7EQ38286095-D83ACF51-93BA-4F75-9C65-C6CC99574D8DQ38514503-282666E9-D170-49F6-9282-3F6E7F75B26CQ38666862-7DC966E6-5D5F-420D-8C28-B733F2F565EEQ38771096-4B2316E5-E6DE-4818-92B6-FB215B55E11EQ39296861-0C899055-D0BB-4D30-8411-22517691526FQ39403785-804707E9-0E0B-4BF3-AC70-9F33BC9366A3Q40086298-B890B2F3-8E0F-4D73-9229-78E2D4520638Q41812231-17C99557-6002-414B-9BE0-0B67D97047E4Q41991684-5420B0AA-182B-4BD7-AB7D-5A21EE919622
P2860
Activating signals dominate inhibitory signals in CD137L/IL-15 activated natural killer cells.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Activating signals dominate in ...... ctivated natural killer cells.
@ast
Activating signals dominate in ...... ctivated natural killer cells.
@en
type
label
Activating signals dominate in ...... ctivated natural killer cells.
@ast
Activating signals dominate in ...... ctivated natural killer cells.
@en
prefLabel
Activating signals dominate in ...... ctivated natural killer cells.
@ast
Activating signals dominate in ...... ctivated natural killer cells.
@en
P2093
P2860
P1476
Activating signals dominate in ...... ctivated natural killer cells.
@en
P2093
Alan S Wayne
Bruce L Levine
Crystal L Mackall
Curt I Civin
Dave F Stroncek
Marianna Sabatino
Sebastien Morisot
Yongzhi Cui
P2860
P304
P356
10.1097/CJI.0B013E31820D2A21
P577
2011-03-01T00:00:00Z